Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant-Reference-Cited by-同舟云学术

Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant

Published:2014-10-08 Issue:14 Volume:312 Page:1409
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Mulligan Mark J.¹,Bernstein David I.²,Winokur Patricia³,Rupp Richard⁴,Anderson Evan⁵,Rouphael Nadine¹,Dickey Michelle²,Stapleton Jack T.³,Edupuganti Srilatha¹,Spearman Paul⁶,Ince Dilek³,Noah Diana L.⁷,Hill Heather⁸,Bellamy Abbie R.⁸

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia

2. Cincinnati Children’s Hospital and Medical Center, University of Cincinnati, Cincinnati, Ohio

3. University of Iowa, Iowa City4Iowa City VA Healthcare System, Iowa City, Iowa

4. University of Texas Medical Branch, Galveston

5. Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia6Division of Pediatric Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia

6. Division of Pediatric Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia

7. Southern Research Institute, Birmingham, Alabama

8. EMMES Corporation, Rockville, Maryland

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A synthetic TLR4 agonist significantly increases humoral immune responses and the protective ability of an MDCK-cell-derived inactivated H7N9 vaccine in mice;Archives of Virology;2024-07-11

2. A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults;Clinical Infectious Diseases;2024-03-27

3. Avian Influenza Outbreaks over the Last Decade;Rising Contagious Diseases;2024-01-05

4. Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults;Vaccine;2024-01

5. Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BIS;Seminars in Immunology;2023-11